a Diagnosis of Any Resectable Lung or Pleural Nodule Clinical Trial
Official title:
A Pilot & Feasibility Study of Intraoperative Imaging With OTL38 In Patients With Lung and Pleural Nodules
This pilot and feasibility study is focusing on patients presenting with suspected malignancies of the lung and pleura who are considered to be good surgical candidates. The primary end-point of the study is to determine the sensitivity of OTL uptake and expression in identifying those lung and pleural nodules when excited by an imaging probe. There will be a single dose of 0.025 mg/kg for intravenous injection over approximately 60 minutes, two to three hours, prior to surgery.
n/a